Arvinas (ARVN) Interest & Investment Income (2017 - 2026)

Arvinas' (ARVN) quarterly Interest & Investment Income came in at $6.4 million in Q1 2026, down 45.3% year-on-year from $11.7 million in Q1 2025, and down 13.51% quarter-over-quarter from $7.4 million in Q4 2025.

Arvinas (ARVN) Interest & Investment Income (2017 - 2026) Analysis & Trends

Arvinas' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $6.4 million for Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 45.3% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $33.1 million, a 36.95% decrease from a year earlier, with the FY2025 full-year figure at $38.4 million, down 29.93% from the prior year.
  • Interest & Investment Income retreated to $6.4 million in Q1 2026 per ARVN's latest filing, from $7.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $14.3 million in Q3 2024 and bottomed at $1.2 million in Q1 2022.
  • The 5-year median for Interest & Investment Income is $9.0 million (2023), against an average of $8.9 million.
  • Across the five-year window, Interest & Investment Income surged 822.55% in 2022 and tumbled 45.3% in 2026, its largest moves.
  • Year by year, Interest & Investment Income stood at $5.7 million in 2022, then soared by 114.04% to $12.2 million in 2023, then grew by 5.74% to $12.9 million in 2024, then tumbled by 42.64% to $7.4 million in 2025, then decreased by 13.51% to $6.4 million in 2026.
  • Per Business Quant, the three latest ARVN Interest & Investment Income figures stand at $6.4 million (Q1 2026), $7.4 million (Q4 2025), and $9.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 44.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 19.51 Mn
10 Arvinas 512.64 Mn -102.26 Mn - 6.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.40 Mn
Dec 31, 2025 7.40 Mn
Sep 30, 2025 9.00 Mn
Jun 30, 2025 10.30 Mn
Mar 31, 2025 11.70 Mn
Dec 31, 2024 12.90 Mn
Sep 30, 2024 14.30 Mn
Jun 30, 2024 13.60 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 12.20 Mn
Sep 30, 2023 10.00 Mn
Jun 30, 2023 9.00 Mn
Mar 31, 2023 7.60 Mn
Dec 31, 2022 5.70 Mn
Sep 30, 2022 3.40 Mn
Jun 30, 2022 1.80 Mn
Mar 31, 2022 1.20 Mn
Dec 31, 2021 620,912.00
Sep 30, 2021 368,545.00
Jun 30, 2021 360,160.00